Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANAPC13 pseudogene 1 (ANAPC13P1) is a human pseudogene related by sequence to the protein-coding gene ANAPC13, which encodes a subunit of the anaphase promoting complex. ANAPC13P1 itself does not code for a functional protein and is generally considered biologically inactive, serving no known direct cellular or disease-related function[7]. If you need a therapeutic target or biologically active form, "ANAPC13" (anaphase promoting complex subunit 13) is a valid protein target involved in cell cycle regulation[1][3][5], but "ANAPC13P1" specifically refers to the pseudogene form, which is not considered a target in pharmacology or molecular biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANAPC13 pseudogene 1 (ANAPC13P1).